Regulation of plasminogen activators and type‐1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes

Glia

Volumn 6, Issue 3, 1992, Pages 163-171

  Tranque, Pedro ^a,b   Robbins, Richard ^a,b   Naftolin, Frederick ^a   Andrade‐Gordon, Patricia ^a  

^a Obstetrics and Gynaecology   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cultured astrocytes; PAI I; Protein kinase C

Indexed keywords

CYCLIC AMP; FORSKOLIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; CHEMISTRY; CONFORMATION; DRUG EFFECT; INTRACELLULAR MEMBRANE; METABOLISM; PHYSIOLOGY; RAT;

ANIMAL; ASTROCYTES; CELLS, CULTURED; CYCLIC AMP; FORSKOLIN; INTRACELLULAR MEMBRANES; MOLECULAR CONFORMATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0027030649     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.440060303     Document Type: Article

References (70)

1. Interaction of heparin with plasminogen activators and plasminogen: Effects on the activation of plasminogen
2. Urokinase‐type plasminogen activator: Proenzime, receptor, and inhibitors
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
4. 3H]ouabain binding and mRNA for isoforms of the sodium pump catalytic subunit in rat brain
5. Modulation by monoamines of somatostatin‐sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures
6. Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide
7. Forskolin, adenylate cyclase, and cell physiology: An overview
8. Plasminogen activators, tissue degradation, and cancer
9. Plasminogen activator and cancer
10. Reverse fibrin autography: A method to detec and partially characterize protease inhibitors after sodium dodecyl sulfate‐polyacrylamide gel electrophoresis
11. Astrocytes lineage. V. Similarity of astrocytes that form in the presence of dBcAMP in cultures to reactive astrocytes in vivo
12. Synaptic remodelling in arcuate nucleus after injection of estradiol valerate in adult female rats
13. Forskolin down‐regulates type‐1 plasminogen activator inhibitor and tissue‐type plasminogen activator and their mRNAs in the human fibrosarcoma cells
14. Concomitant secretion by A431 cells of tissue plasminogen activator and a specific inhibitor masks EGF modulation of tPA activity
15. A study of proteases and protease‐inhibitor complexes in biological fluids
16. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate
17. Protein phosphorylation in astrocytes mediated by protein kinase C: Comparison with phosphorylation by cyclic AMP‐dependent protein kinase
18. Dynamic neuronal‐glial interactions in hypothalamus and pituitary: Implications for control of hormone synthesis and release
19. Tissue coagulation system and fibrinolytic activity of brain tumors
20. Developmental expression of glial‐specific mRNAs in primary cultures of rat brain visualized by in situ hybridization
21. Migration of Schwann cells and wrapping of neurites in vitro: A function of protease activity (plasmin) in the growth medium
22. Schwann cell proliferation and localized proteolysis: Expressionof plasminogen‐activator activity predominates in the proliferating cell populations
23. Developmental transition in plasticity properties of differentiating astrocytes: Age‐related biochemical profile of plasminogen activators in astroglial cultures
24. Partial purification and properties of urokinase inhibitor from human placenta
25. Effects of forskolin on growth and morphology of cultured glial and cerebrovascular endothelial and smooth muscle cells
26. Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
27. Plasminogen activator release at the neuronal growth cone
28. Plasminogen activator secretion by granule neurons in cultures of developing cerebellum
29. Protein Kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells
30. Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells
31. An inhibitor of plasminogen activator in rabbit endothelial cells
32. Induction of plasminogen activator activity by phorbol ester in transformed fetal bovine aortic andothelial cells. Possible independence from protein kinase C
33. Alveolar epithelial cell plasminogen activator
34. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
35. A DNA motif related to the cAMP‐response element and an exon‐located activator protein‐2 binding site in the human tissue‐type plasminogen activator gene promoter cooperate in basal expression and convey activation by phrobol ester and cAMP
36. Synaptic and neuronal‐glial plasticity in the adult oxytocinergic system in response to physiological stimuli
37. Plasminogen activator‐plasmin system and neuronal migration
38. Plasminogen activator is a mitogen for astrocytes in developing cerebellum
39. Effects of phorbol ester on immunoreactive protein kinase C, insulin binding and glucose uptake in astrocytic glial and neuronal cells from the brain
40. Phorbol ester stimulates proliferation of astrocytes in primary culture
41. Effects of norepinephrine on the morphology and some enzyme activities of primary monolayer cultures from rat brain
42. Protein kinase C in primary astrocyte cultures: cytoplasmic localization and translocation by a phorbol ester
43. Regional development of glutamine synthetase activity in the rat brain and its association with the differentiation of astrocytes
44. Response of malignant glioma cell lines to activation an inhibition of protein kinase C‐mediated pathways
45. Synthesis of urokinase‐type plasminogen activator and of type‐1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: Stimulation by phorbol ester
46. Activation of plasminogen: A widespread mechanism for generating localized extracellular proteolysis
47. Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells
48. Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin‐1
49. Neuropeptides modulate the β‐adrenergic response of purified astrocytes in vitro
50. Cell‐associated plasminogen activation: Regulation and physiological functions
51. A plasminogen activator is induced during goldfish optic nerve regeneration
52. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor‐1 from human endothelial cells
53. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis
54. Morphological and biochemical differentiation of glial cells in primary culture
55. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines
56. Evidence for migration of oligodendrocyte‐type‐2 astrocyte progenitor cells into the developing rat optic nerve
57. Plasminogen activator inhibitors
58. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides and prostaglandins
59. Effect of prostaglandins and dibutiryl cyclic AMP on the morphology of cells in primary astroglial cultures and on metabolic enzimes of GABA and glutamate metabolism
60. The expression and localization of urokinase‐type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells
61. Presence and hormonal control of plasminogen activator in granulosa cells of the domestic hen
62. Effects of a phorbol ester, a calcium inophore, and 3,5‐adenosine monophosphate production on hen granulosa cell plasminogen activator activity
63. Secretion of plasminogen activator by cerebral astrocytes and its modulation
64. Corticotropic peptides and melanotropins elevate the level of adenosine 3′:5′‐cyclic monophospahate in cultured murine brain cells
65. Amiloride selectively inhibits the urokinase‐type plasminogen activator
66. Concomitant secretion of prourokinase and of a plasminogen activator specific inhibitor by cultured human monocytes‐macrophages
67. A simple, sensitive, spectrophotometric assay for extrinsic (tissue‐type) plasminogen activator applicable to measurements in plasma
68. Macromolecular interaction on a cAMP responsive region in the urokinase‐type plasminogen activator gene: a role of protein phosphorylation
69. Retinal astrocytes are immigrant from the optic nerve
70. Immunohistochemical demonstration of alpha‐1‐proteinase inhibitor in brain tumors